Downstream processing and chromatography based analytical methods for production of vaccines, gene therapy vectors, and bacteriophages

References

• Wiley and Sons. Gene Therapy Clinical trials Worldwide. Provided by the Journal of Gene Medicine. Updated June 2014, cited September 2014. Available from: http://www.abedia.com/wiley/vectors.php
   Google Scholar
• Afeyan NB, Gordon NF, Mazsaroff I, Varady L, Fulton SP, Yang JB, Regnier FE. Flow-through particles for the high-performance liquid chromatographic separation of biomolecules: perfusion chromatography. J Chromatogr A 1990; 519 (1):1-29; http://dx.doi.org/10.1016/0021-9673(90)85132-F
   Web of Science ®Google Scholar
• Wu Y, Simons J, Hooson S, Abraham D, Carta G. Protein and virus-like particle adsorption on perfusion chromatography media. J Chromatogr A 2013; 1297:96-105; PMID:23726244; http://dx.doi.org/10.1016/j.chroma.2013.04.062
   PubMedGoogle Scholar
• Trilisky EI, Lenhoff AM. Sorption processes in ion-exchange chromatography of viruses. J Chromatogr A 2007; 1142:2-12; PMID:17240385; http://dx.doi.org/10.1016/j.chroma.2006.12.094
   PubMedGoogle Scholar
• Mengran Y, Yan L, Songping Z, Xiunan L, Yanli Y, Yi C, Guanghui M, Zhiguo S. Improving stability of virus-like particles by ion-exchange chromatographic supports with large pore size: advantages of gigaporous media beyond enhanced binding capacity. J Chromatogr A 2014; 1331:69-79; PMID:24485037; http://dx.doi.org/10.1016/j.chroma.2014.01.027
   PubMedGoogle Scholar
• Burden CS, Jin J, Podgornik A, Bracewell DG. A monolith purification process for virus-like particles from yeast homogenate. J Chromatogr B 2012; 880:82-9; http://dx.doi.org/10.1016/j.jchromb.2011.10.044
   PubMed Web of Science ®Google Scholar
• Štrancar A, Podgornik A, Barut M, Necina R. Short monolithic columns as stationary phases for biochromatography. In: Freitag R, editor. Modern advances in chromatography (Advances in Biochemical Engineering/Biotechnology). Berlin: Springer; 2002. 49-85
   Google Scholar
• Segura MM, Puig M, Monfar M, Chillon M. Chromatography purification of canine adenoviral vectors. Hum Gene Ther Meth 2012; 23:182-97; http://dx.doi.org/10.1089/hgtb.2012.058
   Google Scholar
• Lock M, Alvira MR, Wilson JM. Analysis of particle content of recombinant adeno-associated virus serotype 8 vectors by ion-exchange chromatography. Hum Gene Ther Methods 2012; 23:56-64; PMID:22428980; http://dx.doi.org/10.1089/hgtb.2011.217
   PubMedGoogle Scholar
• Bandeira V, Peixoto C, Rodrigues AF, Cruz PE, Alves PM, Coroadinha AS, Carrondo MJ. Holmes. Downstream processing of lentiviral vectors: releasing bottlenecks. Hum Gene Ther Methods 2012; 23(4):255-63; PMID:22934827; http://dx.doi.org/10.1089/hgtb.2012.059
   PubMed Web of Science ®Google Scholar
• Banjac M, Roethl E, Gelhart F, Kramberger P, Lah Jarc B, Jarc M, Štrancar A, Muster T, Peterka M. Purification of Vero cell derived live replication deficient influenza A and B virus by ion exchange monolith chromatography. Vaccine 2014; 32:2487-92; PMID:24631091; http://dx.doi.org/10.1016/j.vaccine.2014.02.086
   PubMed Web of Science ®Google Scholar
• United States Food and Drug Administration (FDA), Guidance for industry PAT—A Framework for Innovative Pharmaceutical Manufacturing and Quality Assurance, September 2004.
   Google Scholar
• Peterka M, Štrancar A, Banjac M, Kramberger P, Maurer E, Muster T, inventors; von Kreisler Selting Werner, representative. Method for influenza virus purification. Chinese State Intellectual Property Office, CN101490248 B, 2013 May 1.
   Google Scholar
• WHO: Weekly Epidemiological Record [Internet]. Switzerland, WHO Geneva. No. 1, 2005;; 80: 1–8. Available from: http://www.who.int/wer
   Google Scholar
• Grachev V, Magrath D, Griffiths E. Requirements for the use of animal cells as in vitro substrates for the production of biologicals. WHO: WHO Technical Report Series; 1998 56p. No. 878, Annex 1: 19-56.
   Google Scholar
• Petricciani J, Sheets R, Stacey G, Bar P and Knezevic I. Recommendations for the evaluation of animal cell cultures as substrates for the manufacture of biological medicinal products and for the characterization of cell banks. WHO, October 2010 94p. Proposed replacement of TRS 878, Annex 1.
   Google Scholar
• FDA Briefing Document. Vaccines and Related Biological Products Advisory Committee Meeting. Cell Lines Derived from Human Tumors for Vaccine Manufacture. September 19, 2012.
   Google Scholar
• Bauer SR, Pilaro AM, Weiss KD. Chapter 21—testing of adenoviral vector gene transfer products: FDA expectations. Adenoviral Vectors Gene Ther 2002; 615-54; http://dx.doi.org/10.1016/B978-012199504-1/50022-5
   Google Scholar
• European Medicines Agency (EMA), Committee for Medicinal Product for Human Use (CHMP). Guideline on quality, non-clinical and clinical aspects of live recombinant viral vectored vaccines. EMA/CHMP/VWP/141697/2009. 2010 June 24, 14.
   Google Scholar
• Food and Drug Administration (FDA), Guidance for Industry: Guidance for Human Somatic Cell Therapy and Gene Therapy. US. Department of Health and Human Services, Food and Drug Administration Center for Biologics Evaluation and Research, March 1998
   Google Scholar
• Woo YJ, Zhang JCL, Taylor MD, Cohen JE, Hsu VM, Sweeney HL. One year transgene expression with adeno-associated virus cardiac gene transfer. Int J Cardiol 2005; 100(3):421-26; PMID:15837086; http://dx.doi.org/10.1016/j.ijcard.2004.09.003
   PubMedGoogle Scholar
• Mbiguino A, Menezes J. Purification of human respiratory syncytial virus: superiority of sucrose gradient over percoll, renografin, and metrizamide gradients. J Virol Methods 1991; 31(2-3):161-70; PMID:1650782; http://dx.doi.org/10.1016/0166-0934(91)90154-R
   PubMedGoogle Scholar
• Peng HH, Wu S, Davis JJ, Wang L, Roth JA, Marini FC, Fang B. A rapid and efficient method for purification of recombinant adenovirus with arginine–glycine–aspartic acid-modified fibers. Anal Biochem 2006; 354(1):140-7; PMID:16707084; http://dx.doi.org/10.1016/j.ab.2006.04.032
   PubMedGoogle Scholar
• Gias E, Nielsen SU, Morgan LAF, Toms GL. Purification of human respiratory syncytial virus by ultracentrifugation in iodixanol density gradient. J Virol Methods 2008; 147(2):328-32; PMID:18029032; http://dx.doi.org/10.1016/j.jviromet.2007.09.013
   PubMedGoogle Scholar
• Trépanier P, Payment P, Trudel M. Concentration of human respiratory syncytial virus using ammonium sulfate, polyethylene glycol or hollow fiber ultrafiltration. J Virol Methods 1981; 3(4):201-11; http://dx.doi.org/10.1016/0166-0934(81)90071-9
   PubMed Web of Science ®Google Scholar
• Smrekar F, Ciringer M, Štrancar A, Podgornik A. Characterisation of methacrylate monoliths for bacteriophage purification. J Chromatogr A 2011; 1218:2438-44; PMID:21238969; http://dx.doi.org/10.1016/j.chroma.2010.12.083
   PubMedGoogle Scholar
• Adriaenssens EM, Lehman SM, Vandersteegen K, Vandenheuvel D, Philippe DL, Cornelissen A, Clokie MRJ, García AJ, Proft M, Maes M, et al. CIM® monolithic anion-exchange chromatography as a useful alternative to CsCl gradient purification of bacteriophage particles. Virology 2012; 434(2):265-70; PMID: 23079104; http://dx.doi.org/10.1016/j.virol.2012.09.018
   PubMed Web of Science ®Google Scholar
• Oksanen HM, Domanska A, Bamford DH. Monolithic ion exchange chromatographic methods for virus purification. Virology 2012; 434:271-7; PMID: 23089255; http://dx.doi.org/10.1016/j.virol.2012.09.019
   PubMed Web of Science ®Google Scholar
• Seigneuret F, Enga M, Roblin A, Pennors M, Toublanc E, Douthe S, Darmon C, Moullier P, Mariau J, Brument N. CIM Monolithic matrix as an efficient and polyvalent tool to prepare and analyze a cGMP compliant batch of recombinant Adenovirus serotype 5. Poster session presented at: 5th Monolith Summer School & Symposium; 2012 June 1-6; Portorož, Slovenia.
   Google Scholar
• Njayou M, Quash G. Purification of measles virus by affinity chromatography and by ultracentrifugation: a comparative study. J Virol Methods 1991; 32(1):67-77; PMID:1648573; http://dx.doi.org/10.1016/0166-0934(91)90186-4
   PubMedGoogle Scholar
• Opitz L, Hohlweg J, Reichl U, Wolff MW. Purification of cell culture-derived influenza virus A/Puerto Rico/8/34 by membrane-based immobilized metal affinity chromatography. J Virol Methods 2009; 161(2):312-6; PMID:19591872; http://dx.doi.org/10.1016/j.jviromet.2009.06.025
   PubMedGoogle Scholar
• Hu J, Ni Y, Dryman BA, Meng XJ, Zhang C. Purification of porcine reproductive and respiratory syndrome virus from cell culture using ultrafiltration and heparin affinity chromatography. J Chromatogr A 2010; 1217(21):3489-93; PMID:20371065; http://dx.doi.org/10.1016/j.chroma.2010.03.023
   PubMed Web of Science ®Google Scholar
• Ohtaki N, Takahashi H, Kaneko K, Gomi Y, Ishikawa T, Higashi Y, Todokoro M, Kurata T, Sata T, Kojima A. Purification and concentration of non-infectious West Nile virus-like particles and infectious virions using a pseudo-affinity Cellufine Sulfate column. J Virol Methods 2011; 174(1-2):131-5; PMID: 21440004; http://dx.doi.org/10.1016/j.jviromet.2011.03.021
   PubMedGoogle Scholar
• Holmes DH. The Effects of Various Physical and Chemical Agents on a Staphylococcus Bacteriophage. Butler University Botanical Studies 1956; 13: Article 8.
   Google Scholar
• Gagnon P. Purification Tools for Monoclonal Antibodies. Validated Biosystems, Inc., Tuscon, AZ, ZDA, 1996, 1-254.
   Google Scholar
• Carta G., Jungbauer A, Downstream Processing of Biotechnology Products. In Protein Chromatography: Process Development and Scale-Up. Wiley-VCH, Weinheim, Germany, 2010; 1-55.
   Google Scholar
• Maurer E, Peterka M, Gassner M, Seper H, Gelhart F, Banjac M, Jarc M, Lah B, Kramberger P, Štrancar A, et al. Influenza virus purification platform. Poster session presented at: 3rd Monolith Summer School & Symposium; June 2008; Portorož, Slovenia.
   Google Scholar
• Flotte TR, Trapnell BC, Humphries M, Carey B, Calcedo R, Rouhani F, Campbell-Thompson M, Yachnis AT, Sandhaus RA, McElvaney NG, et al. Phase 2 clinical trial of a recombinant adeno-associated viral vector expressing a1-antitrypsin: interim results. Hum Gene Ther 2011; 22:1239-47; PMID:21609134; http://dx.doi.org/10.1089/hum.2011.053
   PubMed Web of Science ®Google Scholar
• Lesch HP, Laitinen A, Peixoto C, Vicente T, Makkonen K-E, Laitinen L, Pikkarainen JT, Samaranayake H, Alves PM, Carrondo MJT, et al. Production and purification of lentiviral vectors generated in 293T suspension cells with baculoviral vectors. Gene Ther 2011, 1-8; http://dx.doi.org/10.1038/gt.2010.162
   Web of Science ®Google Scholar
• Forcic D, Brgles M, Ivancic-Jelecki J, Šantak M, Halassy B, Barut M, Jug R, Markušić M, Štrancar A. Concentration and purification of rubella virus using monolithic chromatographic support. J Chromatogr B 2011; 879(13-14):981-6; http://dx.doi.org/10.1016/j.jchromb.2011.03.012
   PubMed Web of Science ®Google Scholar
• Smrekar F, Ciringer M, Peterka M, Podgornik A, Štrancar A. Purification and concentration of bacteriophage T4 using monolithic chromatographic supports. J Chromatogr B 2008; 861(2):177-80; http://dx.doi.org/10.1016/j.jchromb.2007.05.048
   PubMed Web of Science ®Google Scholar
• Kramberger P, Honour RC, Herman RE, Smrekar F, Peterka M. Purification of the Staphylococcus aureus bacteriophages VDX-10 on methacrylate monoliths. J Virol Methods 2010; 166:60-4; PMID:20188758; http://dx.doi.org/10.1016/j.jviromet.2010.02.020
   PubMed Web of Science ®Google Scholar
• Urbas L, Lah Jarc B, Barut M, Zochowska M, Chroboczek J, Pihlar B, Szolajska E. Purification of recombinant adenovirus type 3 dodecahedric virus-like particles for biomedical applications using short monolithic columns. J Chromatogr A 2011; 1218:2451-9; PMID:21295784; http://dx.doi.org/10.1016/j.chroma.2011.01.032
   PubMedGoogle Scholar
• Smrekar F, Ciringer M, Jančar J, Raspor P, Štrancar A, Podgornik A. Optimization of lytic phage manufacturing in bioreactor using monolithic supports. J Sep Sci 2011; 34:2152-8.
   PubMed Web of Science ®Google Scholar
• McIntyre M. Development of viral vectors for use in gene transfer trials; product characterization and quality concerns. Presented at: 8^th Annual Meeting: Viral Vectors & Vaccines; November 2001; Lake Tahoe, Nevada.
   Google Scholar
• Whitfield RJ, Battom SE, Barut M, Gilham DE, Ball PD. Rapid high-performance liquid chromatographic analysis of adenovirus type 5 particles with a prototype anion-exchange analytical monolith column. J Chromatogr A 2009; 1216:2725-9; PMID:19041094; http://dx.doi.org/10.1016/j.chroma.2008.11.010
   PubMedGoogle Scholar
• Transfiguracion J, Bernier A, Arcand N, Chahal P, Kamen A. Validation of a high-performance liquid chromatographic assay for the quantification of adenovirus type 5 particles. J Chromatogr B 2001; 761:187-94; http://dx.doi.org/10.1016/S0378-4347(01)00330-9
   PubMed Web of Science ®Google Scholar
• Transfiguracion J, Berniera A, Voyera R, Coelho H, Coffey M, Kamen A. Rapid and reliable quantification of reovirus type 3 by high performance liquid chromatography during manufacturing of Reolysin®. J Pharm Biomed Anal 2008; 48:598-605; PMID:18632239; http://dx.doi.org/10.1016/j.jpba.2008.05.038
   PubMedGoogle Scholar
• Klyushnichenko V, Bernier A, Kamen A, Harmsen E. Improved high-performance liquid chromatographic method in the analysis of adenovirus particles. J Chromatogr B 2001; 755:27-36; http://dx.doi.org/10.1016/S0378-4347(00)00597-1
   PubMed Web of Science ®Google Scholar
• Urbas L, Mersich C, Paril C, Barut M, Štrancar A. Monolithic columns for the purification, in-process and final control of chimpanzee adenoviruses. Presented at: 5th Monolith Summer School & Symposium; 2012 June 1-6; Portorož, Slovenia.
   Google Scholar
• Shabram PW, Giroux DD, Goudreau AM, Gregory RJ, Hörn MT, Huyghe BG, Liu X, Nunnally MH, Sugarman BJ, Sutjipto S. Analytical anion-exchange HPLC of recombinant type-5 adenoviral particles. Hum Gene Ther 1997; 453-65; PMID:9054520; http://dx.doi.org/10.1089/hum.1997.8.4-453
   PubMedGoogle Scholar
• Blanche F, Cameron B, Barbot A, Ferrero L, Guillemin T, Guyot S, Somarriba S, Bisch D. An improved anion-exchange HPLC method for the detection and purification of adenoviral particles. Gene Ther 2000; 7:1055-62; PMID:10871755; http://dx.doi.org/10.1038/sj.gt.3301190
   PubMedGoogle Scholar
• Phelan MA, Cohen KA. Gradient optimization principles in reversed-phase high-performance liquid chromatography and the separation of influenza virus components. J Chromatogr A 1983; 266:55-66; http://dx.doi.org/10.1016/S0021-9673(01)90879-9
   Web of Science ®Google Scholar
• Calam DH, Davidson J. Isolation of influenza viral proteins by size-exclusion and ion-exchange high-performance liquid chromatography: the influence of conditions on separations. J Chromatogr 1984; 296:285-92; PMID:6480744; http://dx.doi.org/10.1016/S0021-9673(01)96422-2
   PubMedGoogle Scholar
• García-Cañas V, Lorbetskie B, Bertrand D, Cyr TD, Girard M. Selective and quantitative detection of influenza virus proteins in commercial vaccines using two-dimensional high-performance liquid chromatography and fluorescence detection. Anal Chem 2007; 79:3164-72; http://dx.doi.org/10.1021/ac0621120
   PubMed Web of Science ®Google Scholar
• García-Cañas V, Lorbetskie B, Girard M. Rapid and selective characterisation of influenza virus constituents in monovalent and multivalent preparations using non-porous reversed-phase high performance liquid chromatography columns. J Chromatogr A 2006; 1123:225-32; http://dx.doi.org/10.1016/j.chroma.2006.04.003
   PubMed Web of Science ®Google Scholar
• Kapteyn JC, Saidi MD, Dijkstra R, Kars C, Tjon JC, Weverling GJ, de Vocht ML, Kompier R, van Montfort BA, Guichoux JY, et al. Haemagglutinin quantification and identification of influenza A&B strains propagated in PER.C6® cells: a novel RP-HPLC method. Vaccine 2006; 24:3137-44; PMID:16490287; http://dx.doi.org/10.1016/j.vaccine.2006.01.046
   PubMedGoogle Scholar
• Kapteyn JC, Porre AM, de Rond EJP, Hessel WB, Tijms MA, Kessen H, Slotboom AME, Oerlemans MA, Smit D, van der Linden J, et al. HPLC-based quantification of haemagglutinin in the production of egg- and MDCK cell-derived influenza virus seasonal and pandemic vaccines. Vaccine 2009; 27:1468-77; PMID:19110022; http://dx.doi.org/10.1016/j.vaccine.2008.11.113
   PubMed Web of Science ®Google Scholar
• Urbas L, Košir B, Peterka M, Pihlar B, Štrancar A, Barut M. Reversed phase monolithic analytical columns for the determination of HA1 subunit of influenza virus haemagglutinin. J Chromatogr A 2011; 1218:2432-7; PMID:21251658; http://dx.doi.org/10.1016/j.chroma.2010.12.082
   PubMedGoogle Scholar
• Lorbetskie B, Wang J, Gravel C, Allen C, Walsh M, Rinfret A, Li X, Girard M. Optimization and qualification of a quantitative reversed-phase HPLC method for hemagglutinin in influenza preparations and its comparative evaluation with biochemical assays. Vaccine 2011; 29:3377-89; PMID:21397719; http://dx.doi.org/10.1016/j.vaccine.2011.02.090
   PubMed Web of Science ®Google Scholar
• Creskey MC, Li C, Wang J, Girard M, Lorbetskie B, Gravel C, Farnsworth A, Li X, Smith DGS, Cyr TD. Simultaneous quantification of the viral antigens hemagglutinin and neuraminidase in influenza vaccines by LC–MSE. Vaccine 2012; 30:4762-70; PMID:22643214; http://dx.doi.org/10.1016/j.vaccine.2012.05.036
   PubMed Web of Science ®Google Scholar
• Transfiguracion J, Manceur AP, Petiot E, Thompson CM, Kamen A. Particle quantification of influenza viruses by high performance liquid chromatography. Vaccine 2014; 33(1):78-84; PMID:25448111; http://dx.doi.org/10.1016/j.vaccine.2014.11.027
   PubMedGoogle Scholar
• Chahal PS, Transfiguracion J, Bernier A, Voyer R, Coffey M, Kamen A. Validation of a high-performance liquid chromatographic assay for the quantification of Reovirus particles type 3. J Pharm Biomed Anal 2007; 45:417-21; PMID:17692493; http://dx.doi.org/10.1016/j.jpba.2007.06.025
   PubMedGoogle Scholar
• Transfiguracion J, Coelho H, Kamen A. High-performance liquid chromatographic total particles quantification of retroviral vectors pseudotyped with vesicular stomatitis virus-G glycoprotein. J Chromatogr B 2004; 813:167-73; http://dx.doi.org/10.1016/j.jchromb.2004.09.034
   PubMed Web of Science ®Google Scholar
• Transfiguracion J, Mena JA, Aucoin MG, Kamen A. Development and validation of a HPLC method for the quantification of baculovirus particles. J Chromatogr B 2011; 879:61-8; http://dx.doi.org/10.1016/j.jchromb.2010.11.011
   PubMed Web of Science ®Google Scholar
• Shytuhina A, Pristatsky P, He J, Casimiro DR, Schwartz RM, Hoang VM, Ha S. Development and application of a reversed-phase high-performance liquid chromatographic method for quantitation and characterization of a chikungunya virus-like particle vaccine. J Chromatogr A. Forthcoming 2014. http://dx.doi.org/10.1016/j.chroma.2014.05.087
   PubMed Web of Science ®Google Scholar
• O`Keefe DO, Paiva AM. Assay for Recombinant hepatitis B surface antigen using reversed-phase high-performance liquid chromatography. Anal Biochem 1995; 230:48-54; PMID:8585629; http://dx.doi.org/10.1006/abio.1995.1436
   PubMedGoogle Scholar
• Urbas L, Brument N, Ruščić J, Marc D. CIMac analytical columns for in-process control of adenoviruses. Presented at: Engineering Conferences International, 2014 June 8-13; Paradisus Playa del Carmen, Mexico.
   Google Scholar
• Heukeshoven J, Dernick R. Reversed-phase high-performance liquid chromatography of virus proteins and other large hydrophobic proteins in formic acid containing solvents. J Chromatogr 1982; 252:241-54; PMID:6304128; http://dx.doi.org/10.1016/S0021-9673(01)88415-6
   PubMedGoogle Scholar
• Heukeshoven J, Dernick R. Reverse-phase high-performance liquid chromatography of virus proteins and other hydrophobic proteins. Chromatographia 1984; 19:95-100; http://dx.doi.org/10.1007/BF02687724
   Web of Science ®Google Scholar
• Yuan Y, Shane E, Oliver C. N. Reversed-phase high-performance liquid chromatography of virus-like particles. J Chromatogr A 1998; 816:21-8; PMID:9741097; http://dx.doi.org/10.1016/S0021-9673(98)00065-X
   PubMedGoogle Scholar
• TriMark Publications, LLC. Bioseparation systems for global biopharmaceutical markets. August 2013, TMRBIOS13-0801.
   Google Scholar
• Peixoto C, Ferreira TB, Sousa MFQ, Carrondo MJT, Alves PM. Towards purification of adenoviral vectors based on membrane technology. Biotechnol Prog 2008; 24:1290-6; PMID:19194943; http://dx.doi.org/10.1002/btpr.25
   PubMed Web of Science ®Google Scholar
• Slepushkin V, Chang N, Cohen R, et al. Large-scale purification of a lentiviral vector by size exclusion chromatography or Mustang Q ion exchange capsule. Bioproc J 2003; 2(5):89-95.
   Google Scholar
• Rodrigues T, Carvalho A, Roldao A, Carrondo MJT, Alves PM, Cruz PE. Screening anion-exchange chromatographic matrices for isolation of onco-retroviral vectors. J Chromatogr B 2006; 837:59-68; http://dx.doi.org/10.1016/j.jchromb.2006.03.061
   PubMed Web of Science ®Google Scholar
• Mundle S, Anderson S, inventors; Michaud SM, agent. Purification of flaviviruses. World Intellectual Property Organisation, WO 2013/106337 A1, 2013 July 18.
   Google Scholar
• Gerster P, Kopecky EM, Hammerschmidt N, Klausberger M, Krammer F, Grabherr R, Mersich C, Urbas L, Kramberger P, Paril T, et al. Purification of infective baculoviruses by monoliths. J Chromatogr A 2013; 1290:36- 45; PMID:23587319; http://dx.doi.org/10.1016/j.chroma.2013.03.047
   PubMed Web of Science ®Google Scholar
• Vicente T, Peixoto C, Carrondo MJT, Alves PM. Purification of recombinant baculoviruses for gene therapy using membrane processes. Gene Ther 2009; 16:766-75; PMID:19340018; http://dx.doi.org/10.1038/gt.2009.33
   PubMed Web of Science ®Google Scholar
• Gutiérrez-Aguirrea I, Banjac M, Steyer A, Poljšak-Prijatelj M, Peterka M, Štrancar A, Ravnikar M. Concentrating rotaviruses from water samples using monolithic chromatographic supports. J Chromatogr A 2009; 1216:2700-4; http://dx.doi.org/10.1016/j.chroma.2008.10.106
   PubMed Web of Science ®Google Scholar
• Peixoto C, Sousa MFQ, Silva AC, Carrondo MJT, Alves PM. Downstream processing of triple layered rotavirus like particles. J Biotech 2007; 127:452-61; http://dx.doi.org/10.1016/j.jbiotec.2006.08.002
   PubMed Web of Science ®Google Scholar
• Vicente T, Sousa MFQ, Peixoto C, Mota JPB, Alves PM, Carrondo MJT. Anion-exchange membrane chromatography for purification of rotavirus-like particles. J Membrane Sci 2008; 311:270-83; http://dx.doi.org/10.1016/j.memsci.2007.12.021
   Web of Science ®Google Scholar